The Impact of Lung Cancer in Bhutan: A Growing Concern
03-Aug-2024Bhutan, a pristine Himalayan kingdom known for its commitment to Gross National Happiness (GNH), is facing a growing health challenge: lung cancer.
Azista Bhutan Healthcare Limited (ABHL) is making significant strides in Bhutan’s pharmaceutical sector, driven by a commitment to innovation and social responsibility. A joint venture between Azista Industries Pvt Ltd., India, and Druk Holding and Investments Ltd. (DHI), ABHL has launched a state-of-the-art pharmaceutical manufacturing plant at Motanga Industrial Park.
Cancer, a word that strikes fear into the hearts of millions, is an uphill battle for patients and their families worldwide. We at Azista Bhutan are deeply committed to improving the lives of people affected by cancer. Our homegrown pharmaceutical company is dedicated to making high-quality, affordable cancer medications accessible to everyone in Bhutan.
Cancer, a complex and diverse group of diseases, is characterized by the uncontrolled growth and spread of abnormal cells in the body. Each cancer is unique, and understanding the extent of its spread is crucial for developing an effective treatment plan.